Xinjun Wang Selected Research

Inflammation (Inflammations)

1/2023	Mechanism of LEF1-AS1 regulating HUVEC cells by targeting miR-489-3p/S100A11 axis.
10/2021	Transcriptomic Evaluation of Juvenile Localized Scleroderma Skin With Histologic and Clinical Correlation.
1/2020	Curcumin attenuates inflammation and cell apoptosis through regulating NF-κB and JAK2/STAT3 signaling pathway against acute kidney injury.
2/2019	Rational design of 5-((1H-imidazol-1-yl)methyl)quinolin-8-ol derivatives as novel bromodomain-containing protein 4 inhibitors.
1/2018	In vivo evidence for the contribution of peripheral circulating inflammatory exosomes to neuroinflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinjun Wang Research Topics

Disease

36	Neoplasms (Cancer) 01/2024 - 12/2011
12	Glioma (Gliomas) 09/2022 - 10/2015
7	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 01/2019
6	Carcinogenesis 05/2022 - 10/2014
5	Inflammation (Inflammations) 01/2023 - 01/2018
4	Infections 01/2023 - 03/2020
4	Neoplasm Metastasis (Metastasis) 12/2021 - 12/2011
4	Endometrial Neoplasms (Endometrial Cancer) 10/2014 - 01/2013
3	Brain Neoplasms (Brain Tumor) 07/2023 - 07/2017
3	Constipation 01/2019 - 01/2015
2	Hypoxia (Hypoxemia) 01/2024 - 09/2015
2	Persistent Vegetative State (Vegetative State) 01/2022 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2021
2	Circulating Neoplastic Cells 01/2021 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2018 - 08/2015
1	Central Nervous System Diseases (CNS Diseases) 03/2024
1	Diffuse Intrinsic Pontine Glioma 07/2023
1	Stroke (Strokes) 02/2023
1	Atherosclerosis 02/2023
1	Diabetes Mellitus 02/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Drug Resistant Epilepsy 01/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023
1	Clostridium Infections 01/2023
1	Sepsis (Septicemia) 01/2023
1	Gingivitis 09/2022
1	Periodontal Pocket (Periodontal Pockets) 09/2022
1	Periodontitis 09/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 05/2022
1	Cholangiocarcinoma 05/2022
1	Ulcerative Colitis 02/2022
1	Wounds and Injuries (Trauma) 02/2022
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2022
1	Coma (Comas) 01/2022

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2024 - 12/2011
9	Biomarkers (Surrogate Marker)IBA 02/2023 - 12/2011
8	Long Noncoding RNAIBA 01/2023 - 12/2011
6	RNA (Ribonucleic Acid)IBA 03/2023 - 12/2020
6	Messenger RNA (mRNA)IBA 01/2022 - 10/2015
5	CytokinesIBA 01/2023 - 01/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 02/2019
3	MicroRNAs (MicroRNA)IBA 12/2021 - 04/2017
3	Small Interfering RNA (siRNA)IBA 01/2021 - 08/2015
2	UbiquitinIBA 01/2024 - 01/2022
2	Ligases (Synthetase)IBA 01/2024 - 01/2022
2	Therapeutic UsesIBA 01/2024 - 01/2022
2	CholesterolIBA 02/2023 - 01/2022
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2023 - 01/2022
2	AntioxidantsIBA 09/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2013
2	ParaffinIBA 01/2022 - 01/2021
2	EnzymesIBA 01/2022 - 01/2019
2	Cytokine Receptors (Cytokine Receptor)IBA 01/2022 - 12/2021
2	Progestins (Progestagens)IBA 10/2014 - 01/2014
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2013 - 01/2013
1	Neuroprotective AgentsIBA 03/2024
1	GTP-Binding Proteins (G-Protein)IBA 03/2024
1	Estrogen Receptor alphaIBA 03/2024
1	Estrogens (Estrogen)FDA Link 03/2024
1	Cullin Proteins (Cullins)IBA 01/2024
1	dipinacoline glutamateIBA 07/2023
1	Glutamine (L-Glutamine)FDA Link 02/2023
1	Indicators and Reagents (Reagents)IBA 02/2023
1	trimethyloxamine (trimethylamine N-oxide)IBA 02/2023
1	LDL Lipoproteins (beta Lipoproteins)IBA 02/2023
1	Triglycerides (Triacylglycerol)IBA 02/2023
1	Butyrates (Butyrate)IBA 01/2023
1	SolutionsIBA 09/2022
1	ChromiumIBA 09/2022
1	Drug CarriersIBA 09/2022
1	PolyphenolsIBA 09/2022
1	HydrogelsIBA 09/2022
1	Linoleic Acid (Linoleate)IBA 05/2022
1	glycolaldehydeIBA 05/2022
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 02/2022
1	Dextrans (Dextran)FDA Link 02/2022
1	Galla chinensisIBA 02/2022
1	ChromatinIBA 02/2022
1	Ubiquitin-Specific ProteasesIBA 02/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	CyclinsIBA 01/2022
1	OxysterolsIBA 01/2022
1	Intrinsically Disordered ProteinsIBA 01/2022
1	Suppressor of Cytokine Signaling ProteinsIBA 01/2022
1	chrysinIBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022
1	Galectin 1 (LGALS1)IBA 01/2022

Therapy/Procedure

17	Therapeutics 03/2023 - 01/2014
6	Drug Therapy (Chemotherapy) 01/2023 - 11/2012
4	Immunotherapy 01/2023 - 01/2021
4	Electroacupuncture 01/2019 - 01/2012
3	Radiotherapy 01/2023 - 11/2012
2	Transcranial Direct Current Stimulation 01/2022 - 01/2020
1	Sodium-Restricted Diet (Diet, Sodium Restricted) 02/2023
1	Fecal Microbiota Transplantation 01/2023
1	Vagus Nerve Stimulation 01/2023
1	Microspheres (Microsphere) 09/2022
1	Chemoradiotherapy 02/2022